GlassScriptPhysician profile
William T Marshall
NPI 1174533061
$16,810.28
in general payments reported to CMS, 2019-2025
25 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $13K · 2021: $351 · 2022: $342 · 2023: $240 · 2024: $2,395 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,925 · Travel and Lodging: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,924.73 |
| Travel and Lodging | $1,196.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,129.74 | 2019-2025 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $1,917.94 | 2022-2024 | Allevyn Gentle Border 10 X 10cm Ctn 10, Versajet, Oasis |
| Kerecis Limited | $316.76 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $251.48 | 2022-2025 | Puraply Wound Matrix, Apligraf |
| Allergan, INC. | $236.85 | 2019-2021 | |
| Csl Behring | $147.32 | 2022-2023 | Kcentra |
| Integra Lifesciences Corporation | $144.31 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Takeda Pharmaceuticals U.S.A., INC. | $134.29 | 2020-2023 | Gattex |
| Kci USA, INC. | $60.96 | 2020-2023 | Activ.A.C. |
| Biotronik INC. | $48.53 | 2020-2021 | |
| Dilon Technologies, INC. | $43.89 | 2025 | Hemoblast Bellows |
| W. L. Gore & Associates, INC. | $43.12 | 2020 | |
| Lemaitre Vascular, INC. | $41.79 | 2022-2024 | Trivex System |
| Solventum Corporation | $38.49 | 2024-2025 | Activ.A.C. |
| Tei Biosciences INC | $37.67 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $35.58 | 2025 | Nuzyra |
| Davol INC. | $24.51 | 2021 | |
| Stryker Corporation | $23.91 | 2025 | Mako |
| Abbott Laboratories | $21.48 | 2023 | |
| Abbvie INC. | $20.64 | 2024 | |
| Endo Pharmaceuticals INC. | $20.53 | 2021 | |
| Tela Bio, INC. | $19.73 | 2024 | Ovitex 2s |
| Shire North American Group INC | $19.36 | 2019 | |
| Medtronic, INC. | $18.15 | 2023 | Pteye Parathyroid Detection System |
| Merck Sharp & Dohme LLC | $13.25 | 2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.